Company Valuation: MEDICLIN AG

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 186.2 171 130.2 115 175.8 204.2 - -
Change - -8.16% -23.89% -11.68% 52.89% 16.22% - -
Enterprise Value (EV) 186.2 171 130.2 115 175.8 204.2 204.2 204.2
Change - -8.16% -23.89% -11.68% 52.89% 16.22% 0% 0%
P/E - - - - - - - -
PBR 1.02x 0.82x 0.66x 0.52x 0.71x 0.72x 0.64x 0.57x
PEG - - - - - - - -
Capitalization / Revenue 0.28x 0.24x 0.18x 0.15x 0.22x 0.26x 0.25x 0.25x
EV / Revenue 0x 0x 0x 0x 0x 0.26x 0.25x 0.25x
EV / EBITDA 0x 0x 0x 0x 0x 1.79x 1.77x 1.77x
EV / EBIT 0x 0x 0x 0x 0x 3.29x 3.27x 3.26x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 - - - - 0.04 0.04 0.04 0.04
Rate of return - - - - 1.08% 0.93% 0.93% 0.93%
EPS 2 - - - - - - - -
Distribution rate - - - - - - - -
Net sales 1 673.1 704.7 730.1 748.8 784.5 787.5 803.2 819.3
EBITDA 1 85.22 90.92 98.73 103.8 115.6 114.3 115.3 115.6
EBIT 1 11.56 19.52 12.72 53.49 55.36 62.11 62.47 62.72
Net income 1 1.461 9.441 -10.78 24.84 25.49 36.66 38.2 40.12
Net Debt - - - - - - - -
Reference price 2 3.920 3.600 2.740 2.420 3.700 4.300 4.300 4.300
Nbr of stocks (in thousands) 47,500 47,500 47,500 47,500 47,500 47,500 - -
Announcement Date 3/30/22 3/31/23 3/27/24 3/28/25 3/27/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
32.02x3.05x13.63x1.36% 17.93B
52.57x4.48x29.48x0.26% 13.51B
19.85x2.32x10.83x0.63% 12.37B
22.63x3.18x11.35x1.9% 12.11B
25.92x2.09x16.82x0.15% 10.57B
19.71x2.87x11.79x4.05% 9.69B
52.67x6.89x28.91x0.11% 7.58B
34.27x0.95x7.84x1.89% 7.29B
Average 32.46x 3.23x 16.33x 1.29% 11.38B
Weighted average by Cap. 32.05x 3.20x 16.28x 1.25%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield